A synthetic 29-amino acid analogue corresponding to the N-terminal active fragment of endogenous growth hormone-releasing hormone (GHRH). Binds GHRHR on pituitary somatotrophs, stimulating GH secretion. Used extensively in pituitary research and GH axis characterization.
Free COA included · Free shipment protection · 99%+ purity by HPLC & MS · Lyophilized powder
Every batch independently tested by U.S.-accredited labs. Lot-matched COA confirms identity, purity ≥99% by HPLC, and safety screening.
Sermorelin (GHRH(1-29)-NH₂) is the biologically active N-terminal 29-residue fragment of the 44-amino acid native growth hormone-releasing hormone. It retains full receptor-binding and GH-secretory activity relative to the full-length peptide in preclinical models, making it the standard reference agonist for pituitary GHRH receptor (GHRHR) research.
In vitro studies using somatotroph cell cultures and GHRHR-expressing heterologous systems have characterized sermorelin's receptor binding kinetics, cAMP induction, and GH secretion dose-response relationships. It has been used as a positive control compound in screening assays for novel GHRH analogues.
Animal model research has examined sermorelin's effects on pulsatile GH secretion patterns, IGF-1 production, and somatotroph cell biology. Pharmacokinetic studies have characterized its rapid plasma clearance compared to longer-acting GHRH analogues such as CJC-1295 with DAC, providing a useful pharmacological contrast for mechanism studies.
All referenced studies are preclinical or in vitro. Not for human use.
| Full Name / IUPAC | Sermorelin |
| CAS Number | 86168-78-7 |
| Molecular Formula | C₁₄₉H₂₄₆N₄₄O₄₂S |
| Molecular Weight | 3,357.9 g/mol |
| Sequence / Structure | GHRH(1-29)-NH₂ · 29 residues |
| Appearance | White lyophilized powder |
| Solubility | Soluble in sterile water or 0.1% acetic acid |
| Format | Lyophilized (freeze-dried) powder |
| SKU | CL-014 |